Vol.47,Issue 3,October 2026

Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer patients: a systematic review and single arm meta-analysis

Real-world data on predictors of survival in patients with gynecological tumors following pelvic arterial embolization

Incidence and clinical course of lymphoceles following pelvic sentinel lymph node removal in endometrial cancer

Mismatch repair status in endometrial cancer: detection with immunohistochemical markers and its relationship with clinical outcome

Comparative outcomes of MPPE and segmental rectosigmoid resection in cytoreductive surgery for advanced ovarian cancer

OATH trial: a phase II trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer

Sophoraflavanone G decreases the migratory ability of cancer cells by altering the cytokine profile of the environment in endometrial cancer and macrophage co-culture

p53 protein expression, TP53 gene mutations, and in silico p53 activity as prognostic markers for ovarian cancer

Breast cancer: is the current screening appropriate?The RISCAM study

Enhanced recovery after surgery (ERAS) for laparoscopic hysterectomy in low-risk endometrial cancer: a randomized controlled trial

Clinicopathological significance of immunohistochemical expression of p53 and PTEN in endometrial carcinoma

Successful treatment of primary non-gestational choriocarcinoma of the uterine cervix in a postmenopausal woman

Disease-free survival following total pelvic exenteration in localized platinum-resistant recurrent ovarian clear cell carcinoma: a case report

Eflapegrastim-induced large vessel vasculitis in patient treated with recurrent uterine leiomyosarcoma

A case of complete uterine prolapse complicated by cervical squamous cell carcinoma likely unrelated to HPV

Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer

Correction: Subjective perceptions of breast cancer treatment experiences in women: a Q methodological approach

Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model

Correction: Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer

Correction: Prognostic value of Ki-67 in patients with ovarian cancer

Correction: Ecliptae Herba extracts suppress cell proliferation and induce cell apoptosis of ovarian cancer cells by inactivating PI3K/AKT signaling pathway

Correction: Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey

Correction: Taraxasterol stimulates apoptosis of BCa cells via restraining PI3K/AKT and epidermal growth factor receptor (EGFR)

Correction: Investigating the relationship between breast cancer and the postmenopausal period: a systematic meta-analysis

Correction: The cytotoxic, genotoxic and apoptotic effects of an adsorbent and anti‑oxidative vaginal gel on human cervical cancer cell (HeLa) lines

Correction: Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer

Correction: Comparison of the diagnostic efficacy of DWI and DCE-MRI in depth of myometrial invasion, cervical invasion and FIGO staging in patients with endometrial cancer

Correction: Comparison of results of HPV infections and dysplastic changes of the uterine cervix in populations in Vojvodina (north region of Serbia) and Republic of North Macedonia

Correction: Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer

Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2

Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation

Correction: FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1

Correction: CPNE1 as prognostic marker and regulator of cell growth and glycolysis in endometrial cancer

Correction: SHCBP1 a potential target in ovarian cancer growth and stemness

Correction: Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma

Correction: Value of ultrasonic shear wave elastography combined with vascularization-flow index in differential diagnosis of benign and malignant breast tumors in the elderly

Correction: Clinicopathological features and oncological prognosis in ovarian metastasis of the primary origin: a single-center retrospective study

Correction: Downregulation of PHLDA2 promotes apoptosis and autophagy in endometrial cancer cells while inhibiting their proliferation and metastasis

Correction: Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV)

Correction: Delayed colposcopy outcomes and risk factors at a tertiary center in Turkey during the COVID-19 pandemic

Correction: The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review

Correction: The role of biochemical parameters and preoperative ultrasonographic markers in detecting malignancy in adnexal masses

Correction: Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis

Correction: FKBP10 ablation promotes breast cancer chemosensitivity via targeting autophagy and the AKT/CREB axis

Retraction: Effects of docetaxel combined with radiotherapy on immune function, tumor marker indices, and suppression of gene inactivation in breast cancer patients

Retraction: The effects of adjunctive interventions on cervical skin health post-chemotherapy: a systematic review and meta-analysis